Trial · NCT04234698
Results by group214
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 214
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Time to Diagnose NVAF by Each OAC Treatment | Warfarin | 71 | Standard Deviation 230.8 | Days | |
| Time to Diagnose NVAF by Each OAC Treatment | NOACs - Rivaroxaban | 324 | Standard Deviation 712.2 | Days | |
| Time to Diagnose NVAF by Each OAC Treatment | NOACs - Apixaban | 218 | Standard Deviation 541.2 | Days | |
| Time to Diagnose NVAF by Each OAC Treatment | NOACs - Dabigatran | 406 | Standard Deviation 676.0 | Days | |
| Number of Participants With Comorbidities | Warfarin | Diabetes Mellitus | 100 | Participants | |
| Number of Participants With Comorbidities | NOACs | Diabetes Mellitus | 370 | Participants | |
| Number of Participants With Comorbidities | Warfarin | Liver Disease | 5 | Participants | |
| Number of Participants With Comorbidities | NOACs | Liver Disease | 25 | Participants | |
| Number of Participants With Comorbidities | Warfarin | Hypertension | 386 | Participants | |
| Number of Participants With Comorbidities | NOACs | Hypertension | 1430 | Participants | |
| Number of Participants With Comorbidities | Warfarin | Rheumatic disease | 23 | Participants | |
| Number of Participants With Comorbidities | NOACs | Rheumatic disease | 58 | Participants | |
| Number of Participants With Comorbidities | Warfarin | Acquired Immune Deficiency Syndrome (AIDS) | 0 | Participants | |
| Number of Participants With Comorbidities | NOACs | Acquired Immune Deficiency Syndrome (AIDS) | 0 | Participants | |
| Number of Participants With Comorbidities | Warfarin | Chronic Kidney Disease | 196 | Participants | |
| Number of Participants With Comorbidities | NOACs | Chronic Kidney Disease | 892 | Participants | |
| Number of Participants With Comorbidities | Warfarin | Moderate Renal Disease | 163 | Participants | |
| Number of Participants With Comorbidities | NOACs | Moderate Renal Disease | 661 | Participants | |
| Number of Participants With Comorbidities | Warfarin | Congestive Heart Failure | 86 | Participants | |
| Number of Participants With Comorbidities | NOACs | Congestive Heart Failure | 231 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04234698/results